share_log

Cantor Fitzgerald Reiterates Overweight on Asensus Surgical, Maintains $1 Price Target

Benzinga ·  Aug 22, 2023 10:37

Cantor Fitzgerald analyst Ross Osborn reiterates Asensus Surgical (AMEX:ASXC) with a Overweight and maintains $1 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment